Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer

Author： Sugiura Takahiko   Ariyoshi Yutaka   Negoro Shunichi   Nakamura Shinichiro   Ikegami Harumichi   Takada Minoru   Yana Takashi   Fukuoka Masahiro  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.4, 2005-08, pp. : 331-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study

By Takeda Koji   Takifuji Nobuhide   Negoro Shunichi   Furuse Kiyoyuki   Nakamura Shinichiro   Takada Yoshiki   Hoso Takanobu   Hayasaka Shinichi   Nakano Takashi   Araki Jun   Senba Hiroshi   Iwami Fumiyuki   Yamaji Yasufumi   Fukuoka Masahiro   Ikegami Harumichi  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

By Sawa Toshiyuki   Yana Takashi   Takada Minoru   Sugiura Takahiko   Kudoh Shinzoh   Kamei Tadashi   Isobe Takeshi   Yamamoto Hidehiko   Yokota Soichiro   Katakami Nobuyuki   Tohda Yuji   Kawakami Akira   Nakanishi Yoichi   Ariyoshi Yutaka  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

By Ho Cheryl   Davies Angela   Sangha Randeep   Lau Derick   Lara Primo   Chew Helen   Beckett Laurel   Mack Philip   Riess Jonathan   Gandara David  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1587-1591

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

By Yana Takashi   Negoro Shunichi   Takada Minoru   Yokota Soichiro   Takada Yoshiki   Sugiura Takahiko   Yamamoto Hidehiko   Sawa Toshiyuki   Kawahara Masaaki   Katakami Nobuyuki   Ariyoshi Yutaka   Fukuoka Masahiro  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 253-258

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

By Okamoto Isamu   Miyazaki Masaki   Morinaga Ryotaro   Kaneda Hiroyasu   Ueda Shinya   Hasegawa Yoshikazu   Satoh Taroh   Kawada Akira   Fukuoka Masahiro   Fukino Koichi   Tanigawa Takahiko   Nakagawa Kazuhiko  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 844-853

Springer Publishing Company

Access to resources Recommend Favorite